Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patti, Ferguson"'
Autor:
Sarah E Ward, Mona R Loutfy, Lawrence M Blatt, Katharine A Siminovitch, Jiabing Chen, Anna Hinek, Bryan Wolff, Dieu H Pham, Hassan Deif, Elizabeth A LaMere, Kevin C Kain, Gabriella A Farcas, Patti Ferguson, Mary Latchford, Gary Levy, Liasum Fung, James W Dennis, Enoch KY Lai, Eleanor N Fish
Publikováno v:
Antiviral Therapy. 10:263-275
Severe acute respiratory syndrome (SARS), caused by a novel coronavirus, emerged in early 2003 as a major international health crisis. We report on serum cytokine levels, viral load and clinical parameters over the course of the disease in a cohort o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3c4bb8fa2ec34038011696009144651
https://doi.org/10.1177/135965350501000210
https://doi.org/10.1177/135965350501000210
Autor:
Sarah E, Ward, Mona R, Loutfy, Lawrence M, Blatt, Katharine A, Siminovitch, Jiabing, Chen, Anna, Hinek, Bryan, Wolff, Dieu H, Pham, Hassan, Deif, Elizabeth A, LaMere, Kevin C, Kain, Gabriella A, Farcas, Patti, Ferguson, Mary, Latchford, Gary, Levy, Liasum, Fung, James W, Dennis, Enoch K Y, Lai, Eleanor N, Fish
Publikováno v:
Antiviral therapy. 10(2)
Severe acute respiratory syndrome (SARS), caused by a novel coronavirus, emerged in early 2003 as a major international health crisis. We report on serum cytokine levels, viral load and clinical parameters over the course of the disease in a cohort o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2fda5944f5a7bb2cd14160f963842f7e
https://pubmed.ncbi.nlm.nih.gov/15865221
https://pubmed.ncbi.nlm.nih.gov/15865221
Autor:
Elizabeth A. LaMere, Mary Latchford, Enoch K. Y. Lai, Gabriella A. Farcas, James W. Dennis, Mona R. Loutfy, Patti Ferguson, Sarah E. Ward, Gary A. Levy, Margaret Chang, Eleanor N. Fish, Bryan Wolff, Hassan Deif, Kevin C. Kain, Hyoung Lho, Dieu H. Pham, Katharine A. Siminovitch, Lawrence M. Blatt
Publikováno v:
JAMA. 290:3222
ContextSevere acute respiratory syndrome (SARS) is a new clinical entity for which no effective therapeutic strategy has been developed.ObjectiveTo provide preliminary results on the potential therapeutic benefit and tolerability of interferon alfaco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffb4d86d1d2e0e7208b5a1989002bb83
https://doi.org/10.1001/jama.290.24.3222
https://doi.org/10.1001/jama.290.24.3222